Insulin Pump Therapy in Type 1 Diabetes-a Real-World Study of Mortality and Clinical Outcomes

被引：0
作者：
Haughton, Sophie
Riley, David
Arshad, Muhammad Fahad
Azmi, Shazli
Malik, Rayaz A.
Alam, Uazman
Iqbal, Ahmed
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-946-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
946-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Use of sensor-integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real-world study in the UK
    Choudhary, P.
    de Portu, S.
    Arrieta, A.
    Castaneda, J.
    Campbell, F. M.
    DIABETIC MEDICINE, 2019, 36 (09) : 1100 - 1108
  • [22] Insulin Therapy Is Associated With an Increased Risk of Carotid Plaque in Type 2 Diabetes: A Real-World Study
    Ke, Jiang-Feng
    Wang, Jun-Wei
    Zhang, Zhi-Hui
    Chen, Ming-Yun
    Lu, Jun-Xi
    Li, Lian-Xi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [23] REAL-WORLD ROLLOUT OF AUTOMATED INSULIN DELIVERY IN TYPE 1 DIABETES PREGNANCY
    Murphy, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A10 - A11
  • [24] Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study
    Wilmot, Emma G.
    Close, Kelly L.
    Jurisic-Erzen, Dubravka
    Bruttomesso, Daniela
    Ampudia-Blasco, F. Javier
    Bosnyak, Zsolt
    Roborel de Climens, Aude
    Bigot, Gregory
    Peters, Anne L.
    Renard, Eric
    Berard, Lori
    Calliari, Luis Eduardo
    Seufert, Jochen
    DIABETES OBESITY & METABOLISM, 2021, 23 (08) : 1892 - 1901
  • [25] Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis
    Gabler, Maximilian
    Picker, Nils
    Geier, Silke
    Foersch, Johannes
    Aberle, Jens
    Martin, Stephan
    Riedl, Matthias
    Wilke, Thomas
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 174
  • [26] Effectiveness and Tolerability of Vildagliptin plus Metformin Dual Therapy Compared with Insulin Secretagogue plus Metformin Dual Therapy in Patients with Type 2 Diabetes-A Real-World Study (China PDS)
    Chen, Lixian
    Han, Ying
    Hu, Daqing
    Jin, Hui
    Yang, Nailong
    Shi, Xiaoyun
    Li, Quanmin
    Liang, Linlang
    Zang, Li
    Liu, Mingming
    He, James
    Mu, Yiming
    DIABETES, 2018, 67
  • [27] Real-world comparative outcomes study in US patients with type 2 diabetes initiating basal insulin analogues
    Davis, K. L.
    Meyers, J. L.
    Tangirala, M.
    Wei, W.
    DIABETOLOGIA, 2012, 55 : S384 - S384
  • [28] IDegAsp treatment in adults with type 2 diabetes in real-world practice: clinical outcomes by prior therapy subgroup
    Fulcher, G.
    Al-Jaser, S. J.
    Medina, J.
    Mohamed, M.
    Nicodemus, N. A., Jr.
    Olsen, A. H.
    Singh, K. P.
    Yadav, G.
    Kok, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [29] Safety and Clinical Outcomes of Insulin Degludec in Korean Patients with Diabetes in Real-World Practices: A Prospective, Observational Study
    Lee, Byung Wan
    Ahn, Kyu Jeung
    Cho, Ho Chan
    Lee, Eun Young
    Min, KyungWan
    Dahaoui, Amine
    Jeong, Jin Sook
    Lim, Hyo Jin
    Jang, Hak Chul
    DIABETES THERAPY, 2023, 14 (10) : 1659 - 1672
  • [30] PREDICTORS AND CLINICAL OUTCOMES OF TREATMENT INTENSIFICATION IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON BASAL INSULIN IN A REAL-WORLD SETTING
    Kallenbach, Lee
    Shui, Amy M.
    Cheng, Wendy Y.
    Fan, Tao
    Hu, Wenli
    Zichlin, Miriam L.
    Duh, Mei Sheng
    Ye, Fen
    Levin, Philip A.
    ENDOCRINE PRACTICE, 2018, 24 (09) : 805 - 814
12345